DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers

NCT05770037 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Haematological Malignancy
Malignant Neoplasm
Lymphoproliferative Disorders
Neoplasms by Histologic Type
Neoplasms by Site
Cancer
Anaplastic Large Cell Lymphoma
Lymphoma
Renal Cell Carcinoma
Neuroblastoma
Solid Tumour

Interventions

DRUG: Alectinib

Sponsor

Cancer Research UK

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]